{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:27:17Z","timestamp":1790296037771,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mcg.0b013e31824c0dea","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T10:14:13Z","timestamp":1333534453000},"page":"e1-e6","source":"Crossref","is-referenced-by-count":72,"title":["A Survey of Current Practice of Venous Thromboembolism Prophylaxis in Hospitalized Inflammatory Bowel Disease Patients in the United States"],"prefix":"10.1097","volume":"47","author":[{"given":"Andrew","family":"Tinsley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Naymagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind J.","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Sachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210305","first-page":"399","article-title":"Mortality in Crohns diseasea clinical analysis.","volume":"71","author":"Andrews","year":"1989","journal-title":"Q J Med"},{"key":"R2-2-20210305","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ibd.21417","article-title":"Long-term complications, extraintestinal manifestations, and mortality in adult Crohns disease in population-based cohorts.","volume":"17","author":"Peyrin-Biroulet","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R3-2-20210305","first-page":"199","article-title":"Mortality and causes of death in patients with chronic inflammatory bowel disease in Gijon, Asturias (Spain).","volume":"91","author":"Saro Gismera","year":"1999","journal-title":"Rev Esp Enferm Dig"},{"key":"R4-2-20210305","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0037-1615600","article-title":"The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.","volume":"85","author":"Bernstein","year":"2001","journal-title":"Thromb Haemost"},{"key":"R5-2-20210305","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/qjmed\/90.3.183","article-title":"Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden.","volume":"90","author":"Jackson","year":"1997","journal-title":"QJM"},{"key":"R6-2-20210305","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10620-005-1588-y","article-title":"Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia.","volume":"50","author":"Oldenburg","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R7-2-20210305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0025-6196(12)65200-8","article-title":"Vascular complications of inflammatory bowel disease.","volume":"61","author":"Talbot","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"R8-2-20210305","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and coagulation in inflammatory bowel disease: the clot thickens.","volume":"102","author":"Danese","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R9-2-20210305","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00054725-200407000-00007","article-title":"Formation of platelet-leukocyte aggregates in inflammatory bowel disease.","volume":"10","author":"Irving","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"R10-2-20210305","first-page":"513","article-title":"Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease.","volume":"28","author":"van Wersch","year":"1990","journal-title":"J Clin Chem Clin Biochem"},{"key":"R11-2-20210305","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ibd.21334","article-title":"Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention.","volume":"17","author":"Zitomersky","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R12-2-20210305","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"R13-2-20210305","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R14-2-20210305","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.","volume":"60","author":"Kappelman","year":"2011","journal-title":"Gut"},{"key":"R15-2-20210305","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.","volume":"139","author":"Novacek","year":"2010","journal-title":"Gastroenterology"},{"key":"R16-2-20210305","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"R17-2-20210305","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with Enoxaparin Study Group.","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"R19-2-20210305","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition).","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"R20-2-20210305","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults.","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"R21-2-20210305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.crohns.2007.11.002","article-title":"European evidence-based consensus on the management of ulcerative colitis: current management.","volume":"2","author":"Travis","year":"2008","journal-title":"J Crohns Colitis"},{"key":"R22-2-20210305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohns disease: special situations.","volume":"4","author":"Van Assche","year":"2010","journal-title":"J Crohns Colitis"},{"key":"R23-2-20210305","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ajg.2011.53","article-title":"Venous thromboembolism in inflammatory bowel disease: an epidemiological review.","volume":"106","author":"Murthy","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R24-2-20210305","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ncpgasthep0190","article-title":"Therapy insight: vascular complications in patients with inflammatory bowel disease.","volume":"2","author":"Koutroubakis","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R27-2-20210305","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjmed.2011.04.011","article-title":"Longer lengths of stay and higher risk of mortality among inpatients of physicians with more years in practice.","volume":"124","author":"Southern","year":"2011","journal-title":"Am J Med"},{"key":"R28-2-20210305","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2036.2007.03445.x","article-title":"Differences in the management of Crohns disease among experts and community providers, based on a national survey of sample case vignettes.","volume":"26","author":"Esrailian","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R29-2-20210305","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2036.1997.00252.x","article-title":"Treatment of corticosteroid-resistant ulcerative colitis with heparina report of 16 cases.","volume":"11","author":"Evans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"R30-2-20210305","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1572-0241.1999.01143.x","article-title":"Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.","volume":"94","author":"Folwaczny","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R31-2-20210305","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.wnl.0000176073.80532.a2","article-title":"Prevention of venous thrombosis in patients with acute intracerebral hemorrhage.","volume":"65","author":"Lacut","year":"2005","journal-title":"Neurology"},{"key":"R32-2-20210305","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s10620-010-1530-9","article-title":"Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohns disease: a US national practice survey comparing experts and non-experts.","volume":"56","author":"Swaminath","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R33-2-20210305","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/MCG.0b013e3182192207","article-title":"Current practice and perception of screening for medication adherence in inflammatory bowel disease.","volume":"45","author":"Trindade","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R34-2-20210305","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/ibd.21667","article-title":"Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge.","volume":"17","author":"Wasan","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R35-2-20210305","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11894-010-0155-7","article-title":"Quality of care in inflammatory bowel disease.","volume":"13","author":"Shah","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"R36-2-20210305","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.","volume":"371","author":"Cohen","year":"2008","journal-title":"Lancet"},{"key":"R37-2-20210305","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1378\/chest.06-2993","article-title":"Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.","volume":"132","author":"Tapson","year":"2007","journal-title":"Chest"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004836-201301000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:39:50Z","timestamp":1786048790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-201301000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31824c0dea","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}